Archives: Ipos

Jio Platforms is a B2B2C company that commenced its business on November 15, 2019, under Reliance Industries Ltd., with the aim of expanding its presence in the telecommunications industry under a separate name and with the support of an experienced management team. The company provides platforms for digital products and services, such as JioSaavn, JioAICloud and JioPC, and has expanded into the entertainment segment through JioHotstar, following its merger with The Walt Disney Company, with a controlling stake of 63.2%, strengthening its presence in international markets. Another major service provided by the company is digital connectivity, which includes 4G and 5G networks, delivering pan-India coverage to over 99% of the population for wireless broadband as of June 30, 2026. Through its penetration strategy, the company has managed to capture an approximate 60% market share in the industry within a relatively short period. The company also provides applications such as the MyJio app, which enables customers to manage their benefits and other subscriptions offered by the company. Jio Platforms has established its presence through offline stores across over 1,000 cities, with more than 1,000 Jio Centres and over 6,000 Jio Points, indicating a strong physical distribution network across India. In addition, the company provides online platforms and 24/7 customer care services. The company also focuses on proprietary technology and has filed over 7,000 patent applications across 4G, 5G, 6G, cloud-native core network architectures, AI-driven network automation and other digital technologies, of which 1,043 had been granted as of June 30, 2026. The company also aims to integrate AI into everyday use by embedding it across its technology stack and offerings, with the objective of achieving Level 4 on the TM Forum’s Autonomous Networks scale, potentially reducing costs and improving margins. 4G and 5G services are among the company’s major revenue drivers. In line with the Indian Government’s Made in India initiative, the company has developed an indigenous, end-to-end 5G technology stack, including its own portfolio of 4G and 5G combination core networks, as well as Operations Support Systems (OSS) and Business Support Systems (BSS), making it one of the few connectivity providers with such a stack deployed at a nationwide scale. In terms of its customer base, the company was serving over 500 million customers as of June 30, 2026.

Paras Healthcare Limited is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through eight hospitals with an aggregate capacity of 2,211 beds as of June 30, 2026, across North India, Bihar and Jharkhand, under the “Paras Health” brand. Its clinical portfolio is anchored by six core specialties, Cardiac Sciences, Oncology, Neurosciences, Gastro Sciences, Orthopaedics and Sports Injury, and Renal Sciences (collectively, “CONGOR”), which contributed 74.7% of FY26 operating revenue. The hospital network comprises four mature facilities in Gurugram, Patna, Panchkula and Darbhanga, two emerging hospitals in Ranchi and Udaipur, and two newer facilities in Srinagar and Kanpur. This portfolio combines established, revenue-generating centres with opportunities to improve occupancy and gain operating leverage at newer facilities. The company also operates Paras Labs, a NABL-accredited central reference laboratory in Gurugram, supporting its diagnostic services. Its flexible operating model includes owned, leased, revenue-sharing and public-private partnership arrangements, enabling calibrated capital deployment. In FY26, the company recorded 1,15,496 inpatient discharges, 7,78,707 outpatient consultations and an average revenue per occupied bed (ARPOB) of Rs. 47,398 per day. Its expansion pipeline includes a planned 300-bed hospital in Gurugram by FY27 and a hospital of up to 500 beds in Ludhiana by FY28, taking targeted bed capacity to 3,011 by March 2028. Growth prospects are supported by rising demand for organized healthcare in underserved markets, increasing penetration of high-value specialties, and the ramp-up of newer hospitals, while execution and capacity utilization remain key monitorables.

Incorporated in 1998, Bonfiglioli Transmissions Ltd. manufactures precision gearboxes, gear motors and mobile drive systems that control the speed, torque and movement of industrial machinery. Its products serve factory automation, wind turbines and heavy off-highway equipment. The company follows a co-engineering model, working directly with original equipment manufacturers (OEMs) to integrate its drive systems into their machines. Since replacing these systems can require design modifications and extensive testing, this creates high switching costs and supports long-term customer relationships. The company operates three manufacturing facilities across Tamil Nadu and Maharashtra, supported by 13 sales offices. Its business is organised into three segments: Industry & Automation Solutions, Off-Highway Mobility Industry and Wind Industry. In the six months ended June 2026, these segments contributed 42.5%, 28.3% and 27.4% of revenue from operations, respectively. (1) Industry & Automation Solutions: This is the company’s largest segment, supplying gear motors and gearboxes used in factory automation and industrial processes across sectors such as food processing, chemicals, packaging and textiles. Its catalogue includes over 10,200 standard product configurations, allowing it to meet diverse machinery requirements. Sales are supported by 44 authorised dealers operating 54 outlets, of which 36 are exclusive to the company. Its broad industrial exposure also limits dependence on any single end-use industry, with no individual industry contributing more than 10% of this segment’s revenue. (2) Wind Industry: This segment manufactures pitch drives, which adjust turbine blade angles, and yaw drives, which orient turbines towards the wind to improve energy generation. Bonfiglioli began domestic production of these systems in 2006 and supplies turbines ranging from 225 kW to 5 MW. Long-standing relationships with wind turbine manufacturers such as Suzlon Energy and Senvion support its market position, while exports provide access to international markets. (3) Off-Highway Mobility Industry: This segment supplies specialised, high-torque drive systems for heavy machinery, including crawler equipment, rotating machinery and concrete mixer trucks. These systems enable machines to move, rotate and handle heavy loads. Qualifying a drive system for a specific machine can take 25-30 months, making supplier replacement difficult once the system is approved. Key customers include JCB India, Schwing Stetter, CNH Industrial and Ajax Engineering. Manufacturing across all three segments is supported by precision gear machining, grinding and heat treatment, which improve component accuracy and durability. In the six months ended June 2026, the company served more than 930 customers directly, with its top 10 OEM customers accounting for less than 31.7% of revenue. Direct sales contributed 60% of revenue, dealers 20% and inter-company sales 20%, the latter primarily comprising products supplied to group entities for onward sale. Bonfiglioli Transmissions benefits from its Italian parent, Bonfiglioli S.p.A., through access to its brand, technical expertise, global customer relationships and research and development capabilities.

Sahajanand Medical Technologies Limited (SMT) is a global medical technology company focused on researching and developing advanced medical devices, specialising in cardiovascular healthcare. The company initiated its R&D activities in 1998 and was incorporated as Sahajanand Medical Technologies Private Limited in 2001. Its R&D-driven business focuses on Class III and Class C/D medical devices across Vascular Intervention and Structural Heart, supported by 75 clinical studies. The Vascular Intervention segment includes coronary stents and coronary balloons, while the Structural Heart segment comprises products such as transcatheter aortic valve implantation (TAVI) systems and occluders. Vascular Intervention contributed 61.1% of revenue in FY26, highlighting its significant role in the company’s business mix. SMT has also developed a sizeable intellectual property portfolio, with 119 patents granted globally, 78 additional patent applications in the pipeline and five design registrations in India. The company received CE certification in 2020 for its in-house developed biodegradable polymer-based sirolimus-eluting stent, Supraflex Cruz, strengthening its product portfolio in coronary Intervention. It also improved the crossing capability of its balloon catheters and patented the AVDC system for its Hydra TAVI, focusing on better device performance during complex procedures. The company conducts R&D at two centres, one in India and the other in Thailand, to support product development. The company has expanded its international presence to 77 countries in FY26, with key markets including Spain, Germany, France, Italy and the UK. Its presence across multiple markets reflects its ability to operate within varied regulatory and procurement frameworks, while ~70-75% of revenue comes from international markets, indicating a strong overseas contribution. To expand its distribution network and market reach, the company acquired distributors, including Imex Clinic Salud S.L. in Spain and Zarek in Brazil, and, in 2019, Vascular Concepts Limited domestically, which helped it enter the Structural Heart segment. In addition, partnerships with Philips India Limited and Insight Lifetech Co., Ltd. aim to provide imaging solutions for interventional cardiologists and strengthen the company’s capabilities in the complex percutaneous coronary intervention (PCI) market.

Zetwerk Manufacturing Businesses Limited is a technology-led, asset-light manufacturing platform serving industrial and consumer goods industries in India and globally. The company integrates third-party suppliers and its own manufacturing facilities through its proprietary technology platform, Zetwerk OS. Its diversified customer base spans renewable energy, utilities, consumer electronics, artificial intelligence infrastructure, aerospace, space and defence, oil and gas, and industrial automation. Its manufacturing capabilities include metal fabrication, sheet metal stamping, injection moulding, assembly, die casting, forging and machining, enabling it to cater to varied industrial requirements. The company operates through three business segments: Manufacturing Business, Ecosystem Business and Civil Infrastructure Works. The Manufacturing Business comprises three product verticals: Energy Products, Precision Products and Capital Goods, with capabilities spanning design, manufacturing, quality control, logistics and compliance. As of FY26, its manufacturing network included 26 facilities across four countries and 6,979 third-party suppliers across 26 countries, including India. This hybrid model enables the company to scale production, execute complex orders and maintain flexibility in capital deployment. The Ecosystem Business, operated under the Terra91 brand, focuses on supplying raw materials and commodities, including ferrous and non-ferrous metals and petrochemicals such as aluminium, zinc, steel, copper and lead. By aggregating procurement requirements, the company aims to improve sourcing efficiency, cost competitiveness and supply-chain reliability. During FY26, this segment served 828 customers and sourced materials from 562 suppliers. Zetwerk has expanded beyond traditional build-to-print manufacturing into original design manufacturing (ODM), while strengthening its presence across international markets and value-added manufacturing. Its technology-enabled operating model, diversified end-market exposure and global supplier network position it to benefit from increasing manufacturing outsourcing, supply-chain diversification and industrial capacity expansion.